Rankings
▼
Calendar
AUPH FY 2006 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
AUPH
Aurinia Pharmaceuticals Inc.
$2B
FY 2006 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$4M
Gross Profit
$3M
83.0% margin
Operating Income
-$24M
-685.7% margin
Net Income
-$23M
-648.7% margin
EPS (Diluted)
$-13.56
Cash Flow
Operating Cash Flow
-$21M
Free Cash Flow
-$22M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$31M
Total Liabilities
$10M
Stockholders' Equity
$20M
Cash & Equivalents
$13M
← FY 2007
All Quarters
